CLINICAL_TRIALS
research
· 2024-11-07
Clinical Trial Update: PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells) [NA]
Summary
The PRELUDE-1 study is a prospective evaluation of radiotherapy-induced biological effects in patients with oligometastatic colorectal cancer limited to the lun…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Cancer Institute, Naples | Conditions: Colorectal Cancer Metastatic | NA | Status: RECRUITING